Details of the Drug
General Information of Drug (ID: DMTBYCY)
| Drug Name |
RX-0201N
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Synonyms | RX-0201-nano; AKT-1 protein kinase inhibitor (oral nanoliposomal formulation, cancer), Rexahn Pharmaceuticals | ||||||||||||||||||
| Indication |
|
||||||||||||||||||
| Cross-matching ID | |||||||||||||||||||
